An Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 29 May 2012
At a glance
- Drugs Hormones; Perifosine; Trastuzumab
- Indications Multiple myeloma; Solid tumours
- Focus Adverse reactions
- Sponsors AEterna Zentaris Inc; AOI Pharmaceuticals; Keryx Biopharmaceuticals
- 25 May 2012 Planned End Date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 25 May 2012 Company added in association field as reported by ClinicalTrials.gov.
- 17 Oct 2011 Planned end date changed from 1 Jul 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.